COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis.

Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis.

But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device?

Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality.

TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.